Skip to content

Clinical trials

Phase 1 Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 1 Clear all

354 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20021
20033
20047
20057
20069
200718
200816
200912
201014
201117
201216
201314
201418
201519
201616
20177
201820
201910
202013
202122
202223
202316
202415
202510
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed250
Unknown status39
Recruiting21
Terminated18
Not yet recruiting11
Active, not recruiting8
Withdrawn5
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical43
Boryung Pharmaceutical Co., Ltd21
Merck Sharp & Dohme LLC17
GlaxoSmithKline14
Sandoz9
AstraZeneca8
Yuhan Corporation8
Bial - Portela C S.A.7
Vanderbilt University7
Addpharma Inc.6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension354
Dyslipidemias30
Hyperlipidemias28
Diabetes Mellitus17
Obesity17
Diabetes Mellitus, Type 215
Cardiovascular Diseases13
Essential Hypertension10
Heart Failure9
Hypercholesterolemia7

Trials

Showing 51 to 75 of 354. Each trial links to its page on Pharma Observatory.

254 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.